rizatriptan has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
rizatriptan: structure given in first source; RN given refers to benzoate
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rizatriptan was also more effective than placebo on most secondary endpoints." | 2.77 | Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial. ( Aurilia, C; Barbanti, P; Bonassi, S; Dall'Armi, V; Egeo, G; Fofi, L; Vanacore, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbanti, P | 1 |
| Fofi, L | 1 |
| Dall'Armi, V | 1 |
| Aurilia, C | 1 |
| Egeo, G | 1 |
| Vanacore, N | 1 |
| Bonassi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double Blind, Controlled Versus Placebo in Parallel Groups, Study to Evaluate the Efficacy of 10 mg Lyophilized Oral Rizatriptan in the Acute Treatment of Migraine in Patients With Unilateral Trigeminal Autonomic Symptoms.[NCT00753311] | Phase 4 | 80 participants (Actual) | Interventional | 2009-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for rizatriptan and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial.
Topics: Adult; Autonomic Nervous System Diseases; Chi-Square Distribution; Double-Blind Method; Female; Func | 2012 |